XML 34 R24.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Organization and Nature of Business (Details) - USD ($) |  |  | 3 Months Ended
--- | --- | --- | ---
Sep. 09, 2021 | Nov. 01, 2019 | Sep. 30, 2022
Cash upon completion of Phase I Clinical Trials |  | $ 1,500,000 |
Cash upon completion of Phase II Clinical Trials |  | 2,500,000 |
Cash upon completion of Phase III Clinical Trials |  | $ 5,000,000 |
TheraCour Pharma Inc |  |  |
Percentage of net sales allocated for royalty payments |  | 15.00% | 15.00%
Series A Convertible Preferred Stock | TheraCour Pharma Inc |  |  |
Percentage of net sales allocated for royalty payments | 15.00% |  |
Cash upon completion of Phase I Clinical Trials | $ 2,000,000 |  |
Cash upon completion of Phase II Clinical Trials | 2,500,000 |  |
Cash upon completion of Phase III Clinical Trials | $ 5,000,000 |  |
Number of shares issuable upon execution of agreement | 100,000 |  |
Threshold period for issuance of shares upon execution of agreement | 30 days |  |
Issuance of shares upon the approval | 50,000 |  |
Initiation of Phase I Clinical Trials Values | $ 1,500,000 |  |
Number of Shares upon initiation of Phase III Clinical Trials | 100,000 |  |
Number of Shares upon Completion of Phase III Clinical Trials | 500,000 |  |
Series A Preferred stock |  |  |
Issuance of shares |  | 75,000 |

X
- Definition The number of shares issuable upon execution of agreement. + References No definition available. + Details
Name: | nnvc_NumberOfSharesIssuableUponExecutionOfAgreement
Namespace Prefix: | nnvc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty expense calculated as a percentage of net sales. + References No definition available. + Details
Name: | nnvc_PercentageOfNetSalesAllocatedForRoyaltyPayments
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, shares, new issues, upon completion of phase III clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodSharesNewIssuesCompletionOfPhase3ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, shares, new issues, upon initiation of phase III clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodSharesNewIssuesInitiationOfPhase3ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, value, new issues, cash upon completion of phase I clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodValueNewIssuesCashUponCompletionOfPhase1ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, value, new issues, cash upon completion of phase II clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodValueNewIssuesCashUponCompletionOfPhase2ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, value, new issues, cash upon completion of phase III clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodValueNewIssuesCashUponCompletionOfPhase3ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition It represents the amount of stock issued during period, value, new issues, upon initiation of phase I clinical trials. + References No definition available. + Details
Name: | nnvc_StockIssuedDuringPeriodValueNewIssuesInitiationOfPhase1ClinicalTrials
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued upon approval. + References No definition available. + Details
Name: | nnvc_StockIssuedUponApproval
Namespace Prefix: | nnvc_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The threshold period for issuance of shares upon execution of agreement. + References No definition available. + Details
Name: | nnvc_ThresholdPeriodForIssuanceOfSharesUponExecutionOfAgreement
Namespace Prefix: | nnvc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nnvc_TheracourPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=nnvc_SeriesAConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |